Moderna (MRNA:NSD) RBC Maintained “Outperform” rating
Analyst Ratings Coverage RBC Capital Markets (Rank#3), reiterated its outlook on Moderna by maintaining an “Outperform” rating. This reaffirmation of confidence was…
Browse research
Analyst Ratings Coverage RBC Capital Markets (Rank#3), reiterated its outlook on Moderna by maintaining an “Outperform” rating. This reaffirmation of confidence was…
Analyst Ratings Coverage Barclays Capital (Rank#23) downgraded its target price for First Quantum Minerals on January 12, 2024, to CAD 12 while…
US Analyst Ratings Name Exchange Symbol Analyst Action Rating Closing Price Target Price Albertsons Companies NYE ACI Tigress Financial Partners Reiterated by…
CDN Analyst Ratings Name Symbol Analyst Action Rating Closing Price Target Price ADENTRA Inc. ADEN:CA CIBC World Markets Target Up Outperform 31.69…
Stock News In Asia, Japan’s Nikkei continued its upward trend, while China’s stock markets remained subdued ahead of a key policy rate…